Infection Control · CDC HICPAC Guidelines

CDC Intravascular Catheter Infection Prevention Guidelines

An operational crosswalk of the CDC Healthcare Infection Control Practices Advisory Committee (HICPAC) guidelines, audit compliance metrics, and maximal sterile barrier precautions.

Clinical Peer Review: Sarah Jenkins, MSN, RN, CRNI, VA-BC Published: October 2026 Verified Board Member →

1. CDC Quality Audit Measures & Compliance Targets

The Centers for Disease Control and Prevention (CDC) HICPAC guidelines establish 5 critical audit domains that acute care hospitals and infusion suites must systematically track to eliminate catheter-related infections:

TABLE 1: CDC INFECTION PREVENTION AUDIT MATRIX
CDC HICPAC Guidelines · Quality Assurance Measures
CDC Audit Domain Operational Audit Criterion Measurement Methodology Target Compliance
Hand Hygiene Cleanse hands immediately prior to accessing any catheter hub Direct covert observation during bedside medication rounds >=95% Compliance
Maximal Sterile Barrier 5-item barrier gear (gown, gloves, mask, cap, full-body drape) Procedural checklist completed by observing clinician 100% Mandatory
CHG Antisepsis Active friction scrub + verified complete air drying Direct visual observation on insertion checklist 100% Mandatory
Femoral Avoidance Avoid femoral vein in adult patients (prefer subclavian / IJ) EHR site documentation audit across ICU beds >=98% Non-Femoral
Daily Line Necessity Documented clinical rationale for catheter presence in chart Daily automated electronic EHR audit / multidisciplinary rounds 100% Daily Review

2. Catheter Replacement Intervals & Site Selection

The CDC guidelines explicitly reject scheduled routine replacement of central lines, PICCs, and implanted ports, as the physical act of catheter replacement introduces fresh bacterial contamination risks. Catheters must be removed only upon clinical indication or suspicion of infection.

For adult central lines, the subclavian vein is preferred over the internal jugular and femoral veins to minimize extraluminal infection risk, provided the patient is not in end-stage renal disease (where subclavian vein stenosis could compromise future arteriovenous fistula creation).

Evidence Base & Literature Citations

  1. O'Grady NP, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections. Am J Infect Control. 2011;39(4 Suppl 1):S1-34. DOI: 10.1016/j.ajic.2011.01.003
  2. Pronovost P, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732. DOI: 10.1056/NEJMoa061115

Clinical Practice Boundary Notice

This protocol provides evidence-based guidance reflecting INS 2024 Standards of Practice and CDC recommendations. Clinical judgment, institutional policy, and patient-specific variables must guide individualized bedside care.